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DAP12-Deficient Mice
Fail to Develop Autoimmunity
Due to Impaired Antigen Priming
This initiates a cascade of protein tyrosine phosphoryla-
tion, which ultimately leads to cellular activation. DAP12
is expressed as a disulfide-bonded homodimer on the
cell surface of NK cells and is noncovalently associated
with the MHC class I receptors KIR2DS, Ly49D, Ly49H,
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‡Eos Biotechnology cells also express DAP12 (Lanier et al., 1998a). MDL-1
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that associate with DAP12 in myeloid cells (Bakker et
al., 1999; Dietrich et al., 2000). Recently, a novel DAP12-
associating receptor, TREM-1, was shown to mediateSummary
the activation of neutrophils and monocytes. This activa-
tion resulted in the induction of proinflammatory cyto-DAP12 is an ITAM-bearing membrane adaptor mole-
cule implicated in the activation of NK and myeloid kines and chemokines (Bouchon et al., 2000). The func-
tion of DAP12-associating receptors in dendritic cellscells. In mice rendered DAP12 deficient by targeted
gene disruption, lymphoid and myeloid development (SIRPb and TREM-2) is as yet unknown (Bouchon et al.,
2000; Dietrich et al., 2000).was apparently normal, although the activating Ly49
receptors on NK cells were downregulated and non- To determine the physiological roles of these DAP12
receptor complexes in NK cells and myeloid cells, wefunctional. To analyze the consequences of DAP12
deficiency in vivo, we examined the susceptibility of generated DAP12-deficient mice by targeted gene dis-
ruption. In this report, we describe the characteristicsDAP122/2 mice to experimental autoimmune encepha-
lomyelitis (EAE). DAP122/2 mice were resistant to EAE of mice lacking DAP12. In addition to the analysis of
DAP122/2 myeloid and NK cell function in vitro, we evalu-induced by immunization with myelin oligodendrocyte
glycoprotein (MOG) peptide. Resistance was associ- ated the immune response in the absence of DAP12
in vivo by subjecting DAP122/2 mice to experimentalated with a strongly diminished production of IFNg by
myelin-reactive CD41 T cells due to inadequate T cell autoimmune encephalomyelitis (EAE). EAE resembles
the human disease multiple sclerosis and is mediatedpriming in vivo. These data suggest that DAP12 signal-
ing may be required for optimal antigen-presenting by the recognition of myelin proteins by Th1 CD41 T
cells. One clinical sign of EAE is an ascending paralysis,cell (APC) function or inflammation.
which is associated with focal areas of inflammation
and demyelination in the central nervous system (CNS).Introduction
The development of EAE is critically dependent on my-
eloid cells both in the induction phase and the effectorNatural killer (NK) cells participate in immune responses
against pathogens, virus-infected cells, and transformed phase (Kuchroo et al., 1995; Racke et al., 1995; Grewal
et al., 1996; Chang et al., 1999). Preliminary findingscells (Trinchieri, 1989; Scott and Trinchieri, 1995; Biron
et al., 1999). Their activity is regulated by receptors for indicated that DAP12 expression was increased in the
microglial cells and macrophages in the CNS duringMHC class I molecules that can either activate or inhibit
cell-mediated cytotoxicity and cytokine production (re- acute EAE (R. H. and J. D. S., unpublished data). This
suggested a possible role for this molecule in the pathol-viewed in Lanier, 1998; Long, 1999). While many of the NK
cell receptors for MHC class I possess immunoreceptor ogy and prompted us to examine EAE induction in
DAP122/2 mice. Here, we show that induction of CNStyrosine-based inhibition motifs (ITIMs) that recruit pro-
tein tyrosine phosphatases and inhibit NK cell function, inflammation and clinical EAE is a DAP12-dependent
process, which suggests a role for DAP12 in APC-medi-several of these class I receptors lack intrinsic signaling
sequences. These receptors contain a charged acidic ated priming of autoreactive T cells in vivo.
amino acid within their transmembrane region that medi-
ates their association with DAP12, a type I membrane Results
protein containing a single immunoreceptor tyrosine-
based activation motif (ITAM) (Lanier et al., 1998). Upon Generation of DAP12-Deficient Mice
receptor cross-linking, the ITAM of DAP12 becomes The Dap12-targeting vector was constructed by using
phosphorylated and acts as a docking site for the Syk a phage clone containing the Dap12 (TYROBP) locus
or ZAP70 protein tyrosine kinases (Lanier et al., 1998a). derived from a 129/SV genomic DNA library. From this
a 3 kb HpaI fragment containing exons I and II and a
3.5 kb HindIII fragment containing exon V were cloned§ To whom correspondance should be addressed (e-mail: lanier@
itsa.ucsf.edu). into the vector in the opposite transcriptional orientation
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Figure 1. Disrupting the Dap12 Gene
The Dap12 gene is shown with restriction enzyme sites X, XhoI; Hp, HpaI; Hd, HindIII; and EI, EcoRI. Exons are represented as black boxes;
the entire Dap12 gene spans 3.8 kb. The gene-targeting vector contains a 59 3.5 kb HpaI fragment and a 39 3.0 kb HindIII fragment as shown
and effectively replaces exons 3 and 4 with the neomycin-resistance gene (neo) flanked by loxP sites (arrowheads). Transfected ES clones
were selected by Southern blot analysis using a 59 external probe (A) in combination with XhoI digestion. Appropriately targeted ES clones
were used for injection of blastocysts after removal of the neomycin cassette by transfection with a plasmid containing the Cre recombinase.
(B) Southern blot analysis of genomic DNA from an F2 offspring derived from heterozygous parents is shown. DNA was digested with EcoRI
and hybridized with the exon 5 probe (B), as shown in (A). (C) Immunohistochemistry of DAP121/1 and DAP122/2 spleens. Cryosections were
stained with affinity-purified rabbit-anti-mouse DAP12 antibody. The B cell area (B), T cell zone (T), red pulp (RP), and marginal zone (MZ) are
indicated. Magnification is 1003.
relative to the loxP-flanked neomycin-resistance gene Dap12 is closely linked to Dap10, another gene encod-
ing a membrane signaling adaptor protein expressed in(Figure 1A). Exons 3 and 4, which encode the transmem-
brane region and part of the cytoplasmic region of NK cells and myeloid cells (Wu et al., 1999). These genes
are located on mouse chromosome 7 in opposite tran-DAP12, including the first tyrosine of the ITAM, were
deleted by this strategy. Embryonic stem (ES) cells, ap- scriptional orientations, and their termination codons
are separated only by 120 bp. Because of the intimatepropriately targeted with this construct, were trans-
fected with a Cre recombinase expression vector to physical vicinity of these two genes, we examined
whether the disruption of Dap12 affected expressionremove the neomycin cassette. Neomycin-sensitive ES
cells were injected into C57BL/6 blastocysts. DAP122/2 of the DAP10 protein. Biochemical analysis of in vitro
cultured NK cells revealed no difference in the levelprogeny, obtained by intercrossing DAP121/2 animals,
resulted in healthy, viable pups at the expected Mende- of DAP10 proteins between DAP121/2 and DAP122/2
animals (data not shown). Therefore, DAP10 expressionlian frequency (Figure 1B). C57BL/6 3 129 F3 mice were
obtained from random intercrosses, and all comparative in DAP12-deficient mice was not affected.
Young adult DAP122/2 mice were normal with respectstudies were conducted using DAP121/2 and DAP122/2
sex- and age-matched littermates. We confirmed the to viability, weight, fertility, growth, and gross anatomy.
A detailed analysis of hematopoietic tissues, includinginactivation of the Dap12 gene by immunohistochemis-
try on cryosections of spleen using an affinity-purified bone marrow, thymus, spleen, and lymph nodes, re-
vealed normal cellularity and a normal composition ofpolyclonal anti-mouse DAP12 antibody. As illustrated in
Figure 1C, DAP12 protein was not detectable in the lymphocyte subsets (data not shown). Interestingly,
analysis of the skin of DAP122/2 mice showed an in-DAP122/2 spleen, whereas staining of a wild-type spleen
clearly demonstrated DAP12 expression in macro- creased number of MHC class II1 dendritic cells in the
dermis as compared to heterozygous controls (data notphages in the red pulp and marginal zones and in den-
dritic cells in the T cell areas. shown), in accordance with the observations by Toma-
EAE in DAP12-Deficient Mice
347
Figure 2. Phenotypic and Functional Analy-
sis of DAP122/2 NK Cells
(A) Flow cytometric analysis of in vitro cul-
tured NK cells from DAP122/2 mice and het-
erozygous littermates. Cells were stained
with FITC-conjugated control Ig, FITC-conju-
gated anti-Ly49A, FITC-conjugated anti-
Ly49D, and FITC-conjugated anti-Ly49H.
(B) Anti-Ly49D mAb–induced redirected lysis
of FcR1 target cells is absent in DAP122/2 NK
cells. Killing of 721.221-CD321 target cells
by in vitro expanded DAP121/2 (circles) and
DAP122/2 NK cells (triangles) in the presence
of 5 mg/ml of control Ig (open symbols) or
anti-Ly49D mAb (closed symbols). Target cell
lysis at several effector:target cell–ratios (E:T)
was measured by using a standard 4 hr 51Cr-
release assay.
(C) Diminished lysis of CHO target cells by
DAP122/2 NK cells. In vitro cultured DAP121/2
(circles) and DAP122/2 NK cells (triangles)
were assayed for lysis of CHO cells as in (B)
in the presence of 5 mg/ml of control Ig (open
symbols) or a blocking anti-Ly49D mAb
(closed symbols).
(D) Lysis of YAC-1 and J774 tumor targets by
in vitro cultured DAP122/2 NK cells is equiva-
lent to cytotoxicity mediated by heterozygous
littermates.
sello et al. (2000 [this issue of Immunity]), who have also Cross-linking the Ly49D by using an anti-Ly49D-spe-
cific mAb triggers NK cells to kill FcR1 target cells (Ma-generated mice with nonfunctional DAP12 receptors.
son et al., 1996). Because DAP12-deficient NK cells
demonstrated a residual amount of Ly49D on their cell
NK Cell Development and Function in DAP122/2 Mice surface, we tested whether these receptors were func-
The frequency and absolute number of NK cells in the tional. As shown in Figure 2B, DAP121/2 NK cells
spleens of DAP122/2 mice were similar to DAP121/2 showed enhanced lysis of the FcR1 721.221 target cells
littermates and wild-type control animals (data not shown). in the presence of the anti-Ly49D 4E5 mAb. In contrast,
Phenotypic analysis of in vitro cultured NK cells revealed although DAP122/2 NK cells displayed increased spon-
that the expression of the DAP12-associating receptor taneous lysis against these target cells, they showed no
Ly49D was dramatically reduced and the expression of enhanced lysis in the presence of anti-Ly49D mAb.
Ly49H was almost completely absent in DAP12-defi- The Ly49D-DAP12 receptor complex has been impli-
cient mice (Figure 2A). Although expression of the acti- cated in the recognition and lysis of the xenogeneic
vating Ly49 isoforms was significantly diminished, the Chinese hamster ovary (CHO) cell line (Idris et al., 1999;
frequency of NK cells reactive with mAb against the Nakamura et al., 1999). In concordance with these find-
inhibitory Ly49 receptors was not substantially different ings, killing of CHO cells by DAP121/2 NK cells was
in DAP122/2 and DAP121/2 littermates. Data are shown blocked in the presence of the neutralizing anti-Ly49D
for NK cells stained with mAb against Ly49A (mAb JR9– 4E4 mAb (Figure 2C). NK cells from DAP12-deficient
318) (Figure 2A), and comparable results were obtained mice, however, inefficiently lysed CHO target cells. The
using mAbs reactive with Ly49C/I (mAb SW5E6) and low level of CHO killing mediated by the DAP122/2 NK
Ly49G2 (mAb 4D11) (data not shown). Therefore, the cells apparently does not involve the residual Ly49D
DAP12-associated activating Ly49 receptors are not re- receptors because this activity was not affected by the
quired for normal expression of the inhibitory Ly49 iso- addition of anti-Ly49D mAb. Together, the impaired kill-
ing of CHO target cells and the absence of anti-Ly49Dforms.
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mAb–redirected lysis against Fc receptor–bearing tar-
gets confirmed that the Ly49D receptors are nonfunc-
tional in DAP12-deficient mice.
While cytotoxicity against CHO target cells was dimin-
ished in DAP122/2 mice, NK cell recognition and lysis
of several mouse tumor cell lines cells (including YAC-1,
IC-21, J774, RMA/S, AK7, and AK40) were comparable
when in vitro cultured splenic NK cells derived from
DAP121/2 and DAP122/2 littermates were used (Figure
2D and data not shown). Therefore, DAP12 is not essen-
tial for cytotoxicity against several mouse tumor–cell
targets.
DAP122/2 Myeloid Cell Function In Vitro
Since DAP12 is expressed by granulocytes, macro-
phages, and dendritic cells, we closely examined these
lineages in DAP122/2 mice. Flow cytometric analysis
of myeloid cells in DAP122/2 spleen and bone marrow
revealed no alterations when compared to analysis of
cells from wild-type or heterozygous animals (data not
shown). In addition, peritoneal macrophages of DAP12-
deficient mice in vitro were fully capable of LPS-induced
nitric oxide and TNF production and phagocytosis of latex
particles (data not shown). Freshly isolated DAP122/2
spleen cells, as well as IL-4- and GM-CSF-cultured bone
marrow–derived dendritic cells, were identical to hetero-
zygous controls with respect to phenotype and the in-
duction of allogeneic T cell proliferation and cytokine
production (data not shown). However, in vitro culture
may bypass DAP12-dependent requirements that are
needed in vivo for optimal APC activation (Inaba et al.,
1994; Galluci et al., 2000). Therefore, we addressed the
immune function in vivo in DAP122/2 mice by using an
experimental disease model.
DAP122/2 Mice Are Resistant to EAE
Figure 3. DAP122/2 Mice Are Resistant to EAESubcutaneous immunization of DAP12 heterozygous
(A) EAE disease course in DAP121/2 mice (n 5 9, closed circles)animals with MOG peptide together with complete
and DAP122/2 mice (n 5 7, open circles). Mice were immunizedFreund’s adjuvant (CFA) and pertussis toxin uniformly
subcutaneously with 50 mg of MOG35–55 peptide in CFA and injectedand reproducibly induced severe encephalomyelitis in intravenously twice with 100 ng of pertussis toxin on days 0 and 2.
all animals. The disease was associated with rapidly Animals were scored for disease as described in the Experimental
progressing ascending paralysis appearing around day Procedures. The disease incidences were 100% (9/9) and 71% (5/7)
for DAP121/2 and DAP122/2 animals, respectively. The mean clinical10–12, which resulted in a protracted disease course.
score of each group is plotted against time after immunization. OneRemission began only around 20 days after the onset
representative experiment out of three is shown.of clinical symptoms (Figure 3A). Strikingly, around 30%
(B) Immunohistochemical analysis of CNS during the onset of EAE.of DAP122/2 mice were completely resistant to EAE.
Spinal cord tissue obtained 13 days after immunization from a
Moreover, most DAP12-deficient animals experienced DAP121/2 animal with clinical score 2 was compared to a MOG-
a very mild disease, which was delayed in onset and immunized DAP122/2 animal without apparent clinical signs of
spontaneously remitted 10–14 days after onset. These disease. Sections were stained with the indicated mAbs to reveal
resident and infiltrating inflammatory cells. The area shown is theoutcomes were observed in three independent experi-
interface between the white and the gray matter of the spinal cordments.
(original magnification was 1253).To examine the influence of DAP12 on the recruitment
(C) Flow cytometric analysis of CNS-derived leukocytes during theof inflammatory cells to the CNS, we performed immuno-
onset of EAE. Total leukocytes were obtained from the whole per-
histochemical studies during the onset of EAE (day 13). fused CNS from individual animals as described in (B) and were
In heterozygous animals (clinical score 2), substantial compared to leukocytes obtained from a nai¨ve, unimmunized
numbers of leukocytes (CD451 cells) were identified in DAP121/2 animal. Staining with anti-CD45 mAb revealed resident
microglial cells (CD45dim) and infiltrating leukocytes (CD45bright).the spinal cord as typical inflammatory vascular cuffs.
CD45bright cells (gated) were analyzed for CD3 expression.CD41 T lymphocytes and CD11b1 myeloid cells infil-
trated the CNS parenchyma (Figure 3B). By contrast, in
clinically healthy DAP122/2 mice that had been immu- mice and heterozygous littermates at the onset of dis-
ease. Relative to the normal CNS, a dramatically in-nized with MOG, only resident microglial cells (CD11b1)
and a few infiltrating macrophages were observed (Fig- creased number of CD45bright infiltrating leukocytes,
including CD31 T cells, was isolated from the EAE-ure 3B). In addition, we performed flow cytometry on leu-
kocytes extracted by perfusion of the CNS of DAP122/2 affected DAP121/2 CNS but not from the CNS obtained
EAE in DAP12-Deficient Mice
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Figure 4. DAP122/2 MOG-Reactive CD41 T
Cells from Peptide Immunized Animals Fail
to Produce IFNg upon Restimulation In Vitro
Mice were immunized subcutaneously with
50 mg of MOG35–55 peptide in CFA, and the
draining lymph nodes were harvested at day
9. Single-cell suspensions were cultured with
various amounts of MOG35–55 peptide or
HEL74–88 control peptide (A). For proliferation
assays, [3H]hymidine was added to the cul-
tures at day 3 for the final 18 hr. DAP121/2
mice are represented by circles, DAP122/2
mice by triangles, MOG peptide by filled sym-
bols, and control peptide by open symbols.
(B) Culture supernatants were collected after
72 hr and were tested for the presence of IFNg
by ELISA. DAP122/2 mice are represented by
open bars, and DAP121/2 mice are represented by closed bars. Draining lymph node cells of two individual animals were pooled, and data
points are the mean values of triplicate cultures. Standard deviations did not exceed 10% of the mean values. One representative experiment
out of five is shown.
from clinically healthy DAP122/2 mice (Figure 3C). Fur- Discussion
thermore, microglial cells (identified as CD45dim cells in
the CNS [Sedgwick et al., 1991]) from MOG-immunized Because DAP12 was originally described as an adaptor
molecule involved in the activation of NK cells, we closelyDAP121/2 but not DAP122/2 animals showed increased
MHC class II expression. These results indicated that examined the NK cell compartment of DAP122/2 mice.
Here, we show that the number of NK cells in adultthese cells had been activated (data not shown). Immu-
nohistochemical analysis of the spinal cord of an af- DAP12-deficient mice is equivalent to that of wild-type
animals. This indicates that DAP12 is not required forfected DAP122/2 animal (day 26, clinical score 2) showed
a qualitatively similar but less severe infiltrate as com- NK cell maturation. Moreover, the proportion of NK cells
pared to a DAP121/2 diseased animal (day 26, clinical in DAP12 null mice expressing the inhibitory Ly49 recep-
score 4) (data not shown). Female DAP122/2 animals tors, including Ly49A, Ly49C/I, and Ly49G2, was not
were somewhat more susceptible to EAE than DAP122/2 substantially different from the proportion in heterozy-
males (data not shown). This may be explained by the gous littermates. Thus, the activating Ly49 receptors
increased disease severity of EAE in female B6.129 mice associated with DAP12 are not required for the expres-
compared to male mice, as previously described (Sa- sion of the inhibitory receptors in this family. The func-
moilova et al., 1998). tion of the activating Ly49 receptors (e.g., Ly49D and
Ly49H), however, is impaired in the DAP122/2 mice. Anti-
bodies against Ly49D failed to activate NK cells isolatedActivation and Differentiation of Myelin-Reactive T
Cells Are Impaired in DAP122/2 Animals from the DAP122/2 mice, showing that other ITAM-bear-
ing receptors, such as FceRIg or CD3z, were not ableResistance to EAE in DAP12-deficient mice could be
due either to the inability of myelin-specific T cells to to compensate for the loss of DAP12. In addition, killing
of the xenogeneic tumor cell target CHO was diminisheddifferentiate into Th1 effector cells in the periphery or
the inability of differentiated effector T cells to migrate in the DAP122/2 mice, and a blocking mAb against Ly49D
inhibited CHO killing by DAP121/2 but not DAP122/2 NKinto the CNS and cause inflammation. In addition, the
resistance might result from impaired DAP122/2 myeloid cells. Similarly, the remarkably diminished expression
of Ly49H in DAP122/2 mice again indicated that DAP12cell–effector function in the CNS. To address the first
possibility, we examined the induction of myelin-reac- is uniquely able to associate with this receptor. The in
vitro killing of several mouse tumor cell lines was nottive CD41 T cells in DAP122/2 mice. Draining lymph
node (DLN) cells from DAP122/2 mice and heterozygous affected in the DAP122/2 mice, and this suggested that
other pathways are involved in these functions. Priorlittermates were harvested 9 days after immunization
with MOG peptide in CFA and tested for their prolifera- studies using FceRIg null or CD3z null mice reported
intact killing of several NK-sensitive targets (Liu et al.,tion and cytokine production in response to restimulation
with peptide in vitro. DLN cells from both DAP12-defi- 1993; Takai et al., 1994). Analysis of FceRIg-CD3z-
DAP12 triple-null mice will answer the question ofcient and heterozygous mice specifically proliferated
in response to MOG-peptide (Figure 4A), although the whether these ITAM-bearing receptors are dispensable
for NK cell cytolytic activity against certain mouse tumorDAP122/2 T cells responded to a lesser extent (z50%).
However, in contrast to MOG-reactive DAP121/2 T cells, cell targets. Further experiments to test the susceptibility
of DAP122/2 mice to pathogens implicated in NK cell–those from DAP122/2 animals did not produce detect-
able levels of interferon-g (IFNg) (Figure 4B), suggesting mediated immunity (e.g., Listeria monocytogenes,
mouse cytomegalovirus, Toxoplasma gondii) will bethat these DAP122/2 CD41 T cells had been inadequately
primed in vivo. The observation that neither T cells from necessary to critically test the biological role of DAP12
in NK cell function in vivo.DAP122/2 mice nor from heterozygous animals pro-
duced detectable levels of IL-4 (data not shown) indi- To address immune function in the absence of DAP12
in vivo, we challenged DAP122/2 mice with MOG peptidecated that the response in the DAP122/2 mice had not
been redirected from a Th1 toward a Th2 phenotype. to induce EAE. DAP12-deficient mice were remarkably
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resistant to disease when compared with their heterozy- Nonetheless, DAP122/2 APC are not completely dys-
functional because in vitro derived bone-marrow den-gous littermates. The experiments described here em-
dritic cells from DAP122/2 mice were capable of inducingployed mice of a mixed C57BL/6 3 129 background. In
a vigorous mixed lymphocyte response when used asall cases, however, DAP121/2 and DAP122/2 littermates
stimulators of allogeneic T cells. In addition, we haveof the same age and sex were compared. The observa-
observed no gross abnormalities in the expression oftion that all DAP121/2 mice were uniformly susceptible
MHC antigens or costimulatory molecules on DAP122/2to EAE, despite the potential variability in the contribu-
APC in vivo or in vitro. Therefore, more subtle alterationstion of randomly segregating C57BL/6 or 129 genes in
in the function of these cells in vivo is likely to be respon-the F3 mice, indicated that neither background overtly
sible for the suboptimal priming of T cells in the DAP122/2affected susceptibility or resistance to the mouse MOG
mice.immunogen. Moreover, wild-type 129 strain mice were
Resistance to EAE has also been observed in CD40found to be susceptible to EAE induction when this proto-
ligand (CD40L)-deficient mice that express a transgeniccol was used to inject them with the mouse MOG peptide
T cell receptor specific for myelin basic protein (MBP)(unpublished data). Extending this argument to the
due to impaired CD80/86 expression on the APC (GrewalDAP122/2 mice, which were uniformly resistant (com-
et al., 1996). Immunization of these mice with MBP pep-pletely or substantially) to EAE, indicates that it is the
tide, along with simultaneous coadministration of CD80-DAP12 null mutation that conferred this resistance, not
overexpressing APC, primed the myelin-reactive T cellsrandomly segregating 129 strain genes.
for IFNg production and induced EAE. These resultsResistance of the DAP122/2 mice to EAE was associ-
demonstrated that restoration of costimulatory activityated with a lack of IFNg production by the myelin-reac-
on APC in vivo could restore EAE induction. Cross-link-tive CD41 T cells in vitro upon recall with MOG peptide.
ing of CD40 on dendritic cells upregulates MHC classThese DAP122/2 CD41 T cells are not intrinsically inca-
II; the costimulatory molecules CD80, CD86, and OX40L;pable of IFNg secretion because cross-linking with anti-
and the chemokine receptor CCR7 and induces IL-12CD3 and anti-CD28 mAb in vitro induced levels of IFNg
production (Ohshima et al., 1997; Grewal and Flavell,production comparable to levels in the CD41 T cells of
1998; Yanagihara et al., 1998). Therefore, the CD40–wild-type control and DAP121/2 mice (data not shown).
CD40L interaction has been implicated as a key media-Therefore, this suggests that the absence of IFNg pro-
tor of dendritic cell maturation. Although CD402/2 miceduction by MOG-reactive CD41 T cells upon antigenic
fail to elicit proper Th1 responses to a number of patho-rechallenge in vitro is the consequence of inadequate
gens, CD40-deficient animals challenged with virusesT cell priming in vivo. Whether the lack of IFNg in MOG-
are able to mount protective CD41 T cell responses thatimmunized DAP12-deficient mice is causal to the ob-
produce normal levels of IFNg (Oxenius et al., 1996).served resistance to EAE is not known. While significant
This suggests the existence of CD40/CD40L-indepen-evidence points to IFNg as a critical proinflammatory
dent mechanisms of CD41 T cell priming. In addition tomediator during the pathogenesis of EAE, disease in-
the CD40/CD40L pathways, other pathways involvingduction can take place in the absence of this cytokine
TNF family members, such as TRANCE-receptor/TRANCEif an immunization regimen employing CFA is used (Fer-
and OX40 ligand/OX40, have been implicated in APC-Tber et al., 1996). The resistance to EAE probably results
cell interactions (Bachmann et al., 1999; Chen et al.,from the failure of DAP122/2 mice to induce autoreactive
1999; Kopf et al., 1999; Murata et al., 2000). Our resultsT cells in response to immunization with MOG peptide.
suggest that DAP12-mediated signaling may constituteIn addition, impaired function of inflammatory macro-
an additional pathway of APC maturation. Because thephages and activated microglial cells in the CNS during
in vivo maturation of dendritic cells may occur in a tem-the effector phase might contribute to the resistance.
poral and spatially sequestered manner, DAP12-medi-In DAP122/2 mice the T cell–priming defect might re-
ated dendritic cell activation may precede or comple-
sult from improper APC function at different stages dur-
ment TNF family–induced dendritic cell maturation.
ing the induction of the immune response. First, there
Recently, Paloneva et al. have reported a cohort of
could be a defect in the activation or maturation of APC patients in Finland and Japan that lacks functional
in the periphery at the site of antigen encounter. Second, DAP12 genes (Paloneva et al., 2000). These individuals
the migration of antigen-loaded macrophages and/or suffer from polycystic lipomembranous osteodysplasia
dendritic cells to the draining lymph nodes might be with sclerosing leukoencephalopathy, also known as
affected. Finally, the priming of naive T lymphocytes Nasu-Hakola disease (Verloes et al., 1997). This reces-
within the T cell zone of the lymph nodes may be insuffi- sive genetic disorder is characterized by systemic bone
cient due to impaired interactions between the DAP12- cysts and progressive presenile frontal-lobe dementia
deficient APC and the antigen-specific T cells. In addi- resulting in death before 50 years of age. Independent
tion to the inefficient priming of naive T cells, the reacti- deletions in the Dap12 genes in the Finnish and Japa-
vation of antigen-reactive CD41 T cells in the CNS by nese patients render the molecule nonfunctional, and
DAP122/2 APC mice might also contribute to disease re- in the Finnish patients the lack of DAP12 was confirmed
sistance. Because DAP12 is expressed predominantly by by Northern and Western blot analysis. Consistent with
APC but is not present in nai¨ve T cells, it seems likely that results obtained in the DAP12-deficient mice, these pa-
the diminished immune response in the MOG-immu- tients have normal numbers of NK cells and their lytic
nized animals results from defects in the APC rather activity against certain NK-sensitive targets (e.g., K562)
than the T cells. Further studies using adoptive transfer is not impaired. Severe immunodeficiencies have not
of DAP12 null and wild-type cell types will be required been observed in these patients; however, they have
not been evaluated for more subtle impairments. Theto dissect the precise mechanism of this phenomenon.
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anti-Ly49D) (Idris et al., 1999), kindly provided by Drs. H. Smith andpredominant pathologies arise in the bones and CNS
W. Yokoyama. Monoclonal antibodies were added to the targetbut are of late onset. We propose that the defects in
cells prior to the addition of effector cells and were used at a finalthe bones and brains of the patients could result from
concentration of 5 mg/ml.
the deficiency of DAP12 in the osteoclasts and microglial
cells in these tissues, respectively. A common link might Induction of EAE
be impaired myeloid function. While initially the lack of EAE was induced in 6- to12-week-old DAP122/2 males and heterozy-
gous littermate controls by subcutaneous injection into the base ofDAP12 might render individuals more resistant to the
the tail and rump. The injection consisted of 50 mg mouse/rat MOGacute onset of autoimmune pathology, as in the case
peptide (39-MEVBWYRSPFSRVVHLYRNGK-59) in complete Freund’sof EAE in mice, it may ultimately be detrimental because
adjuvant (CFA) containing 1 mg per mouse of heat-inactivated Myco-
impaired myeloid cell function due to DAP12-associated bacterium tuberculosis (H37A; DIFCO Labs, Detroit, MI). Pertussis
mechanisms might result in CNS and bone pathology. toxin (100 ng) (LIST biological Labs, Campbell, CA) was injected intra-
We are presently evaluating DAP122/2 mice as they age venously on days 0 and 2. Animals were observed daily, and neuro-
logical effects were quantified on an arbitrary clinical scale: 1, flaccidto see if these features are observed in rodents.
tail; 2, hindlimb weakness or abnormal gait; 3, severe hindlimb weak-
ness with loss of ability to right from supine; 4, hindquarter paralysis;Experimental Procedures
5, forelimb weakness or moribund; and 6, death, as described pre-
viously (Riminton et al., 1998). Supplementary food and water wereGene Targeting
provided on the cage floor for disabled animals.A Dap12 gene–targeting construct was generated using a vector
containing a neomycin-resistance gene (neo), flanked by loxP sites
Immunohistochemistry and Flow Cytometryand multiple cloning sites. At the 39 end a herpes simplex virus
Dissected specimens of nonperfused brain and spinal cord werethymidine kinase gene (HSVtk) was included to permit negative se-
embedded in OCT compound (Tissue Tek, Miles, Elkhart, IN), frozenlection against random integration. An HSVtk promoter drives both
in liquid nitrogen vapor and stored at 2808C until use. Serial cryostatresistance genes. Cells of the embryonic stem (ES)-cell line E14.1
sections (8 mm) were stained with mAbs (YTS-165.1, anti-CD45;were transfected with linearized vector by electroporation. The ES
RM4–5, anti-CD4; M1/70, anti-CD11b; all purchased from Phar-cells were selected using G418 (240 mg/ml) and ganciclovir (2 mM),
Mingen) and visualized by using immunoperoxidase detection re-and homologous recombinants were identified by Southern blot
agents. Sections were counterstained with hematoxylin, as describedanalysis using a probe 59 of the targeting vector in combination with
(Ko¨rner et al., 1997). CNS-associated leukocytes were isolated fromXhoI digestion, as shown in Figure 1. Two ES cell clones showing
collagenase/DNase-digested whole CNS tissue after heparin-salinehomologous recombination of the Dap12 gene were subjected to a
perfusion of animals, and Percoll gradient density centrifugation wassecond round of transfection with a plasmid encoding Cre recombi-
performed as described (Ford et al., 1995). Purified cells were stainednase, and G418-sensitive subclones were selected. Two indepen-
with mAbs (30/F11, biotin-conjugated anti-CD45 mAb 30/F11, visu-dent subclones were injected into C57BL/6 blastocysts, and the
alized by allophycocyanin-conjugated streptavidin; phycoerythrin-resulting male chimeras were mated with C57BL/6 females. Germ-
conjugated anti-CD11b mAb M1/70, fluorescein-conjugated anti-I-Abline transmission was assessed for both clones by coat color, and
mAb AF6–120.7; and fluorescein-conjugated anti-CD3e-mAb 145–the presence of the disrupted Dap12 allele was analyzed by PCR
2C11; all purchased from PharMingen). Cells were analyzed by flowusing genomic DNA isolated from ear punches using the following
cytometry.oligonucleotide primers: wild-type Dap12 sense, 59-TCCTGTGTCC
TCAGCTCATGTTGGG-39; wild-type allele antisense, 59-AGGGCAT
Proliferative Responses of DLN CellsCTGGTGCCATCTTCTGG-39; and knockout antisense, 59-TTGCCA
Mice were immunized subcutaneously with 50 mg of MOG35–55 emul-TGGATGCGTACTAGAGCGG-39. Using these primers, the wild-type
sified in CFA containing 1 mg of M. tuberculosis H37A. Drainingallele generates a 1100 bp fragment, whereas the null allele pro-
lymph nodes (inguinal, popliteal, and para-aortic) were harvestedduces a 600 bp fragment. Heterozygous animals were interbred to
nine days later, and single-cell suspensions were prepared. Wholeobtain homozygous mutant animals. The F3 offspring of DAP122/2 3
lymph node cells were cultured in 96-well plates at 5 3 105 cells/DAP121/2 breeding pairs were used for all experiments described.
well with a range in concentrations of MOG35–55 or control peptide
(HEL74–88, kindly provided by A. O’Garra, DNAX) in RPMI 1640 mediumIn Vitro Analysis of NK Cell Function
containing 10% FCS and 5 3 1025 M 2-ME. Cultures were pulsedAfter hypotonic lysis of red blood cells, NK cells were enriched by
with [3H]thymidine (Amersham) at 1 mCi/well on day 3 for the finaldepletion of surface Ig1 B cells from total spleen-cell populations
18 hr. In parallel wells not radiolabeled, the levels of IFNg and IL-4by using sheep-anti-mouse Ig-coated magnetic beads (Dynal, Oslo,
present in the supernatants after 72 hr of culture were determinedNorway). Subsequently, NK cells were purified by positive selection
by ELISA using anti-mouse IFNg mAbs (R46A2 capture, AN18 detec-using anti-DX51 mAb-coated microbeads and LS columns on a
tion) and anti-mouse IL-4 mAbs (BVD4–1D11 capture, BVD6–24G2MACS separator (Miltenyi Biotec). The NK cells were expanded for
detection).9–12 days in Iscove’s medium containing 10% FCS, 5 3 1025 M
2-ME, 1000 U/ml mouse IL-2 (generously provided by D. Rennick,
AcknowledgmentsDNAX), and 1 ng/ml human IL-15 (Peprotech, Rocky Hill, NJ). The
purity of the NK cells after expansion was approximately 95%. NK
We thank Dr. A. Kane (Brown University, Providence, RI) for her giftcells were analyzed by flow cytometry using the FITC-conjugated
of the AK7 and AK40 cells and Drs. H. Smith, and W. Yokoyama formAbs 145–2C11 (hamster IgG, anti-CD3e), DX5 (rat IgM, pan NK),
generously providing mAbs. We acknowledge Drs. A. Beebe, B.JR9–318 (rat IgG2a, anti-Ly49A), 4E5 (rat IgG2a, anti-Ly49D), and
Homey, and D. Cua for help with animal experiments; M. Bigler for3D10 (mouse IgG1, anti-Ly49H) (Smith et al., 2000) (kindly provided
cell culture; and J. Katheiser, G. Burget, and M. Andonian for graph-by Drs. H. Smith and W. Yokoyama, Washington University, St. Louis,
ics. Schering Plough Corporation supports the DNAX Research Insti-MO). Standard 4 hr 51Cr-release assays were performed as described
tute. The Sandler Family Supporting Foundation partially fundedpreviously (Bakker et al., 1998). Briefly, 1 3 106 target cells were
studies at UCSF.incubated with 100 mCi Na251CrO4 (Amersham) for 1 hr and were
washed extensively. Effector cells were then added to the target
Received June 1, 2000; revised July 27, 2000.cells in triplicate wells of U-bottom microtiter plates (Costar, Cam-
bridge, MA) in a final volume of 150 ml. Monoclonal antibodies used
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